Skip to content

High-frequency peripheral combined central magnetic paired stimulation promotes recovery of motor function in patients with ischemic stroke: a single-center, subject blind, randomized controlled trial

High-frequency peripheral combined central magnetic paired stimulation promotes recovery of motor function in patients with ischemic stroke: a single-center, subject blind, randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400083363
Enrollment
Unknown
Registered
2024-04-23
Start date
2024-05-01
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

treatment group:Pairing frequency: 10Hz, stimulation for 2 seconds, rest for 5 seconds
A total of 1200 pulses of coordinated stimulation
Pairing interval: 25ms
Peripheral stimulation target: median nerve of affected limb
Stimulation intensity: the minimum intensity that can cause wrist movement
Central stimulation target: M1 of affected brain
Stimulation intensity: 100% rMT.
control group:the control group is to set the peripheral stimulation intensity of the PAS group to 0, and the rest are the same as the PAS group

Sponsors

Tongji University Affiliated Tongji Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patients diagnosed with stroke by clinical evaluation and imaging results; (2) The first stroke occurred, and the course of disease was between 3 and 12 months; (3) Aged 45-80, male or female; (4) Brunnstorm 3-4; (5) Normal cognitive function (normal as assessed by the simple mental scale).

Exclusion criteria

Exclusion criteria: (1) There is a serious systemic disease and cannot tolerate rehabilitation treatment; (2) Diagnosed mental illness, major depression, epilepsy or related family history; (3) diabetes, uremia and other serious systemic diseases; (4) Patients with contraindications to transcranial magnetic stimulation and fMRI according to safety guidelines, such as metal or other electronic devices implanted in the body; (5) Application of corticoexcitatory drugs (such as anti-epileptic drugs, anti-anxiety and depression drugs, etc.) within 1 month; (6) During drug or alcohol withdrawal.

Design outcomes

Primary

MeasureTime frame
The Action Research Arm Test (ARAT);

Secondary

MeasureTime frame
Fugl-meyer assessment-upper limbs (FMA-UL);modified barthel Index (MBI);modified Tardieu scale (MTS);functional near-infrared spectroscopy(fNIRS);motor evoked potential (MEP);somatosensory evoked potential (SEP);cortical resting period (CSP);

Countries

China

Contacts

Public ContactChen Yuhui

Tongji University Affiliated Tongji Hospital

1519290335@qq.com+86 66111140

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026